By Christopher Cole ( September 16, 2019, 4:00 PM EDT) -- Surescripts has again urged a D.C. federal judge to reject the Federal Trade Commission's suit over an alleged e-prescription monopoly, arguing that the FTC can't just claim "we know it when we see it" in deciding which legal actions are suited for federal court rather than a commission in-house adjudicatory hearing....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.